Table 2 Clinic characteristics of screening cohort
|  | Healthy control (n  =  4) | T2DM (n  =  4) | DN (n  =  4) |
|---|---|---|---|
Males | 2 (50%) | 2 (50%) | 2 (50%) |
Age (years) | 31 (25–38) | 55 (49–59) | 51 (47–53) |
BMI (kg/m2) | 23.67 (21.68–26.31) | 25.50 (20.57–29.73) | 25.96 (20.02–32.12) |
Total cholesterol (g/L) | – | 5.08 (2.93–6.96) | 4.66 (4.22–5.15) |
Triglyceride (mg/dL) | – | 2.14 (1.17–3.34) | 2.00 (1.68–2.20) |
BUN (mmol/L) | 4.9 (4.1–5.5) | 7.1 (5.6–8.3) | 12.4 (7.5–16.4)**# |
SCr (umol/L) | 70.5 (61.3–79.3) | 81.3 (69.8–91.5) | 161.5 (105.5–219.5)*# |
UA (umol/L) | 310 (294–324) | 308 (269–365) | 333 (308–375) |
Plasma albumin (g/L) | 48 (45–51) | 42 (38–45) | 31 (25–36)**# |
eGFR (ml/min/1.73m2) | 94 (81.3–112.5) | 90 (81.3–101.3) | 57.8 (48.9–67.4)**# |
Urinary ACR (mg/g) | 2.4 (0–8.9) | 55 (5–150) | 579 (208–707)**## |